141 related articles for article (PubMed ID: 34298370)
1. A retrospective study on the efficacy of Ninjin'yoeito on fatigue in patients with interstitial pneumonia.
Kushima H; Kinoshita Y; Fujita M; Ishii H
Neuropeptides; 2021 Oct; 89():102178. PubMed ID: 34298370
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Ninjin'yoeito for Chronic Obstructive Pulmonary Disease Patients with Frailty.
Hirai K; Homma T; Matsunaga T; Akimoto K; Yamamoto S; Suganuma H; Kashima A; Sato H; Ebato T; Miyata Y; Ohta S; Inoue H; Kusumoto S; Suzuki S; Tanaka A; Sagara H
J Altern Complement Med; 2020 Aug; 26(8):750-757. PubMed ID: 32551796
[No Abstract] [Full Text] [Related]
3. Safety and efficacy of Ninjin'yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial.
Yagi T; Sawada K; Miyamoto M; Kinose Y; Nakagawa S; Takiuchi T; Kodama M; Kobayashi E; Hashimoto K; Mabuchi S; Tomimatsu T; Yoshino K; Kimura T
BMC Womens Health; 2022 Jun; 22(1):229. PubMed ID: 35701778
[TBL] [Abstract][Full Text] [Related]
4. Effects of Ninjin'yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial.
Ohbayashi H; Ariga M; Ohta K; Kudo S; Furuta O; Yamamoto A
Int J Chron Obstruct Pulmon Dis; 2024; 19():995-1010. PubMed ID: 38737191
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Ninjin'yoeito in treating severe coronavirus disease 2019 in patients in an intensive care unit.
Aomatsu N; Shigemitsu K; Nakagawa H; Morooka T; Ishikawa J; Yamashita T; Tsuruoka A; Fuke A; Motoyama K; Kitagawa D; Ikeda K; Maeda K; Shirano M; Rinka H
Neuropeptides; 2021 Dec; 90():102201. PubMed ID: 34753072
[TBL] [Abstract][Full Text] [Related]
6. Retrospective evaluation of the effect of Ninjin'yoeito in hepatocellular carcinoma patients treated with lenvatinib.
Toshida K; Itoh S; Yoshizumi T; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Hata K; Makihara Y; Watanabe H; Mori M
Surg Today; 2022 Mar; 52(3):441-448. PubMed ID: 34417867
[TBL] [Abstract][Full Text] [Related]
7. Ninjin'yoeito Improves Genitourinary Symptoms in Patients With Frailty.
Okui N; Okui MA
Cureus; 2023 Jun; 15(6):e40767. PubMed ID: 37363115
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic efficacy of ninjin'yoeito for oxaliplatin-induced cumulative peripheral neuropathy in patients with colorectal cancer receiving postoperative adjuvant chemotherapy: a randomized, open-label, phase 2 trial (HOPE-2).
Motoo Y; Tomita Y; Fujita H
Int J Clin Oncol; 2020 Jun; 25(6):1123-1129. PubMed ID: 32232692
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of Ninjin'yoeito: Absorption and brain distribution of Ninjin'yoeito ingredients in mice.
Matsumoto T; Takiyama M; Sakamoto T; Kaifuchi N; Watanabe J; Takahashi Y; Setou M
J Ethnopharmacol; 2021 Oct; 279():114332. PubMed ID: 34129897
[TBL] [Abstract][Full Text] [Related]
10. A quasi-randomized controlled trial of Ninjin'yoeito for the treatment of postpartum anemia and the prevention of postpartum depression.
Kawakami SI; Fukuda S; Shinbori Y; Umeki M; Mitani M; Kuramoto A; Sugimoto C; Nitta M; Higashi K; Ito M
J Obstet Gynaecol Res; 2022 Nov; 48(11):2830-2838. PubMed ID: 35882511
[TBL] [Abstract][Full Text] [Related]
11. Impact of Ninjin'yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice.
Amitani H; Chiba S; Amitani M; Michihara S; Takemoto R; Han L; Fujita N; Takahashi R; Inui A
Front Pharmacol; 2022; 13():973897. PubMed ID: 36353482
[TBL] [Abstract][Full Text] [Related]
12. Maintaining Weight and Nutritional Status with Ninjin'yoeito in Elderly Patients with Chronic Wasting Diseases.
Nakagawa Y; Kagohashi K; Shioya A; Kinoshita K; Tsuji H; Satoh H
Sultan Qaboos Univ Med J; 2022 May; 22(2):280-282. PubMed ID: 35673286
[TBL] [Abstract][Full Text] [Related]
13. Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study.
Ito T; Konishi A; Tsubokura Y; Azuma Y; Hotta M; Yoshimura H; Nakanishi T; Fujita S; Nakaya A; Satake A; Ishii K; Nomura S
Front Nutr; 2018; 5():72. PubMed ID: 30186837
[TBL] [Abstract][Full Text] [Related]
14. Ninjin'yoeito suppressed the onset of arthritis, pain, and muscle atrophy in rheumatoid arthritis model mice.
Suginohara T; Kawaguchi M; Michihara S; Fujita N; Han LK; Takahashi R
Front Pharmacol; 2022; 13():974380. PubMed ID: 36601050
[TBL] [Abstract][Full Text] [Related]
15.
Shimoyama T; Kaneda M; Yoshida S; Michihara S; Fujita N; Han LK; Takahashi R
Front Pharmacol; 2022; 13():970697. PubMed ID: 36299904
[TBL] [Abstract][Full Text] [Related]
16. Impact of
Okada KI; Kawai M; Hirono S; Miyazawa M; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Shimokawa T; Yamaue H
Curr Ther Res Clin Exp; 2020; 93():100605. PubMed ID: 33014206
[TBL] [Abstract][Full Text] [Related]
17. Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Expression.
Miyamoto A; Asai K; Kadotani H; Maruyama N; Kubo H; Okamoto A; Sato K; Yamada K; Ijiri N; Watanabe T; Kawaguchi T
Int J Chron Obstruct Pulmon Dis; 2020; 15():3063-3077. PubMed ID: 33273811
[TBL] [Abstract][Full Text] [Related]
18. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of a traditional Chinese medicine, ren-shen-yang-rong-tang (Japanese name: Ninjin'yoeito) on nitric oxide-mediated lung injury in a mouse infected with murine cytomegalovirus.
Tanaka K; Sawamura S
Int Immunopharmacol; 2006 Apr; 6(4):678-85. PubMed ID: 16504932
[TBL] [Abstract][Full Text] [Related]
20. Ninjin'yoeito, a herbal medicine, enhances glucose tolerance in mice.
Zhang L; Gopalasingam G; Herzog H
Neuropeptides; 2021 Aug; 88():102150. PubMed ID: 33895618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
